HemaSphere (Jun 2022)
PB1999: ATG-010 PLUS LOW-DOSE DEXAMETHASONE (SD) IN CHINESE RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) PATIENTS PREVIOUSLY RECEIVED CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T)
- W. Fu,
- Z. Xia,
- C. Fu,
- W. Chen,
- C. Chang,
- B. Fang,
- G. An,
- Y. Wei,
- Z. Cai,
- S. Gao,
- J. Weng,
- L. Chen,
- H. Jing,
- F. Li,
- Z. Liu,
- X. Chen,
- J. Liu,
- Y. Yu,
- A. Wang,
- Y. Fei,
- L. Qiu
Affiliations
- W. Fu
- 1 Shangai Changzheng Hospital, Shanghai
- Z. Xia
- 2 Sun Yat-sen University Cancer Center, Guangzhou
- C. Fu
- 3 The First Affiliated Hospital of Soochow University, Suzhou
- W. Chen
- 4 Beijing Chaoyang Hospital, Beijing
- C. Chang
- 5 Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai
- B. Fang
- 6 Henan Cancer Hospital, Zhengzhou
- G. An
- 7 Institute of Hematology and Blood Diseases Hospital, Tianjin
- Y. Wei
- 8 Nanfang Hospital, Guangzhou
- Z. Cai
- 9 The First Affiliated Hospital,Zhejiang University School of Medicine, Hangzhou
- S. Gao
- 10 the First Affiliated Hospital of Jilin University, Changchun
- J. Weng
- 11 Guangdong Provincial People’s Hospital, Guangzhou
- L. Chen
- 12 Jiangsu Province Hospital, First Affiliated Hospital of Nanjing Medical University, Nanjing
- H. Jing
- 13 Peking University Third Hospital, Beijing
- F. Li
- 14 the First Affiliated Hospital of Nanchang University, Nanchang
- Z. Liu
- 15 Shengjing Hospital of China Medical University, Shenyang
- X. Chen
- 16 Xi Jing Hospital affiliated to the Fourth Military Medical University, Xi’An
- J. Liu
- 17 the Third Xiangya Hospital of Central South University, Changsha
- Y. Yu
- 18 Antengene Therapeutics Ltd., Shanghai, China
- A. Wang
- 18 Antengene Therapeutics Ltd., Shanghai, China
- Y. Fei
- 18 Antengene Therapeutics Ltd., Shanghai, China
- L. Qiu
- 7 Institute of Hematology and Blood Diseases Hospital, Tianjin
- DOI
- https://doi.org/10.1097/01.HS9.0000850828.95013.8a
- Journal volume & issue
-
Vol. 6
pp. 1870 – 1871
Abstract
No abstracts available.